undamentalytics Newsletter
Sign in

Institution

Lilly Endowment Inc

13F for September 30, 2026, filed October 19, 2026 · SEC CIK 316011 · Holdings history from March 31, 1999

Reported value
$104.2bn
100% in companies we cover
Positions we cover
1
Largest LLY 100.0%
Copy, a year
+22.0%
S&P 500 +11.4%
Copy Sharpe ratio
0.81
S&P 500 0.60

Copy-performance statistics: January 11, 2008 to November 2, 2026. Holdings history can start earlier than the price data used for performance.

Historical holdings

Holdings across the available history, including securities outside our stock coverage. Select a date to view the holdings for that period.

1 reported entries for September 30, 2026.

IssuerClass / typeReported valueQuantity
Eli Lilly and Company532457108 · LLY Common $104.2bn 90,066,978

Values use the units disclosed in the source. Where a dollar scale cannot be established, the original amount is shown as filed. Rows may include separate allocations, options and principal amounts; these are kept separate from the covered-stock portfolio used for performance.

How copying its 13F would have done

$5.0k$10.0k$20.0k$40.0k$80.0k$160k$320k 2008201020122014201620182020202220242026 $418k$76.0k
CopyS&P 500 $10,000 copying Lilly Endowment Inc's usable filed holdings in companies we cover from January 11, 2008, rebalancing at the first weekly close after each usable filing and holding until the next, against the S&P 500 (total return). Missing prices carry their last observed value. Marked weekly, log scale. Before costs and taxes; misses trading within each quarter and anything 13F does not show (shorts, cash, bonds, non-US holdings).

Biggest drop −47.9% (S&P 500 −50.8%); beta 0.66; alpha +14.8% a year (t = 2.64); last 12 months +63.9% against +12.1%.

Reported value by quarter

Lilly Endowment Inc: 13F reported value Total reported value where the source's dollar units can be established. Earlier filings in thousands of dollars are converted; dates with unresolved value units are omitted.
$0 $50B $100B $150B Reported value, 2013-06-30: $6.7B Reported value, 2013-09-30: $6.8B Reported value, 2013-12-31: $6.9B Reported value, 2014-03-31: $8B Reported value, 2014-06-30: $8.3B Reported value, 2014-09-30: $8.6B Reported value, 2014-12-31: $9.1B Reported value, 2015-03-31: $9.5B Reported value, 2015-06-30: $10.8B Reported value, 2015-09-30: $10.8B Reported value, 2015-12-31: $10.8B Reported value, 2016-03-31: $9.2B Reported value, 2016-06-30: $10B Reported value, 2016-09-30: $10.1B Reported value, 2016-12-31: $9.2B Reported value, 2017-03-31: $10.5B Reported value, 2017-06-30: $10.2B Reported value, 2017-09-30: $10.6B Reported value, 2017-12-31: $10.4B Reported value, 2018-03-31: $9.5B Reported value, 2018-06-30: $10.4B Reported value, 2018-09-30: $12.8B Reported value, 2018-12-31: $13.7B Reported value, 2019-03-31: $15.2B Reported value, 2019-06-30: $12.9B Reported value, 2019-09-30: $13B Reported value, 2019-12-31: $15.1B Reported value, 2020-03-31: $15.7B Reported value, 2020-06-30: $18.3B Reported value, 2020-09-30: $16.4B Reported value, 2020-12-31: $18.8B Reported value, 2021-03-31: $20.6B Reported value, 2021-06-30: $25.1B Reported value, 2021-09-30: $25B Reported value, 2021-12-31: $29.7B Reported value, 2022-03-31: $30.4B Reported value, 2022-06-30: $33.8B Reported value, 2022-09-30: $33.6B Reported value, 2022-12-31: $37.7B Reported value, 2023-03-31: $35.2B Reported value, 2023-06-30: $47.4B Reported value, 2023-09-30: $53.7B Reported value, 2023-12-31: $58.2B Reported value, 2024-03-31: $76.9B Reported value, 2024-06-30: $88.2B Reported value, 2024-09-30: $85.8B Reported value, 2024-12-31: $74.8B Reported value, 2025-03-31: $79.3B Reported value, 2025-06-30: $74.8B Reported value, 2025-09-30: $72.9B Reported value, 2025-12-31: $99.1B Reported value, 2026-03-31: $84.5B Reported value, 2026-06-30: $108.4B Reported value, 2026-09-30: $104.2B 2013-06-30 2016-03-31 2018-12-31 2021-09-30 2024-06-30 2026-09-30 $104.2B
View chart data
Period Reported value
2013-06-30 $6.7B
2013-09-30 $6.8B
2013-12-31 $6.9B
2014-03-31 $8B
2014-06-30 $8.3B
2014-09-30 $8.6B
2014-12-31 $9.1B
2015-03-31 $9.5B
2015-06-30 $10.8B
2015-09-30 $10.8B
2015-12-31 $10.8B
2016-03-31 $9.2B
2016-06-30 $10B
2016-09-30 $10.1B
2016-12-31 $9.2B
2017-03-31 $10.5B
2017-06-30 $10.2B
2017-09-30 $10.6B
2017-12-31 $10.4B
2018-03-31 $9.5B
2018-06-30 $10.4B
2018-09-30 $12.8B
2018-12-31 $13.7B
2019-03-31 $15.2B
2019-06-30 $12.9B
2019-09-30 $13B
2019-12-31 $15.1B
2020-03-31 $15.7B
2020-06-30 $18.3B
2020-09-30 $16.4B
2020-12-31 $18.8B
2021-03-31 $20.6B
2021-06-30 $25.1B
2021-09-30 $25B
2021-12-31 $29.7B
2022-03-31 $30.4B
2022-06-30 $33.8B
2022-09-30 $33.6B
2022-12-31 $37.7B
2023-03-31 $35.2B
2023-06-30 $47.4B
2023-09-30 $53.7B
2023-12-31 $58.2B
2024-03-31 $76.9B
2024-06-30 $88.2B
2024-09-30 $85.8B
2024-12-31 $74.8B
2025-03-31 $79.3B
2025-06-30 $74.8B
2025-09-30 $72.9B
2025-12-31 $99.1B
2026-03-31 $84.5B
2026-06-30 $108.4B
2026-09-30 $104.2B

Latest covered holdings and moves

Covered holdings as of September 30, 2026.

CompanyShare of portfolioValueSharesChange in shares
LLYLilly (Eli)100.00%$104.2bn90.07M−0.3%

None this quarter.

Change in shares on the previous quarter's 13F, valued at this quarter's reported price.

CompanySold (value)Shares
LLYLilly (Eli)−$358.7m−310.0K

Change in shares on the previous quarter's 13F, valued at this quarter's reported price.

No positions in covered companies were sold out this quarter.

  • Health Care100.0%

Share of the value held in companies we cover, by sector.

PeriodCopy, a yearS&P 500SharpeS&P 500Biggest dropBeta
Whole backtestJanuary 11, 2008 to November 2, 2026+22.0%+11.4%0.810.60−47.9%0.66
2010 to 2017January 8, 2010 to December 29, 2017+16.0%+13.5%0.900.98−20.9%0.57
2018 onwardsJanuary 5, 2018 to November 2, 2026+39.1%+13.9%1.100.66−34.5%0.59
Last three yearsNovember 3, 2023 to November 2, 2026+36.2%+21.8%0.901.16−34.5%0.51
Last yearNovember 7, 2025 to November 2, 2026+54.0%+14.2%1.370.84−18.6%−0.03

From SEC Form 13F data sets. A 13F lists long positions in US-listed shares at the quarter's end, filed up to 45 days later; it does not show shorts, cash, bonds, non-US holdings or trades within the quarter. Positions in companies outside our coverage are not listed here. Research, not investment advice.